Opioids compared to placebo or other treatments for chronic low-back pain-Reference-Cited by-同舟云学术

Opioids compared to placebo or other treatments for chronic low-back pain

Published:2013-08-27 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Chaparro Luis Enrique¹,Furlan Andrea D²,Deshpande Amol³,Mailis-Gagnon Angela⁴,Atlas Steven⁵,Turk Dennis C⁶

Affiliation:

1. Hospital Pablo Tobon Uribe; Anesthesiology Department; Medellin Colombia

2. Institute for Work & Health; 481 University Avenue, Suite 800 Toronto ON Canada M5G 2E9

3. University Health Network; TWH-Comprehensive Pain Unit; 399 Bathurst St 4th Floor Toronto ON Canada M5T 2S8

4. Toronto Western Hospital Comprehensive Pain Program; Department of Medicine; 399 Bathurst Street Fell Pavillion 4F811 Toronto Ontario Canada M5T 2S8

5. Massachusetts General Hospital; Medical Practices Evaluation Center; 50 Staniford Street 9th Floor Boston MA USA 02114

6. University of Washington; Department of Anesthesiology and Pain Medicine; Box 356540 Seattle Washington USA 98195

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD004959.pub4/fullpdf

Reference103 articles.

1. Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study;Buynak;Expert Opinion on Pharmacotherapy,2010

2. Analgesic tolerance without demonstrable opioid-induced hyperalgesia: A double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain;Chu;Pain,2012

3. Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase;Gordon;Clinical Therapeutics,2010

4. Efficacy and safety of OPANA ER (Oxymorphone Extended Release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: A 12-week, randomized, double-blind, placebo-controlled study;Hale;Journal of Pain,2007

5. Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain;Hale;Current Medical Research and Opinion,2010

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the impact of health-care access on the severity of low back pain by country: a case study within the GBD framework;The Lancet Rheumatology;2024-09

2. Prolonged opioid use after single-level lumbar spinal fusion surgery in a Belgian population: a multicentric observational study;European Spine Journal;2024-08-21

3. Psychophysiologic symptom relief therapy for chronic back pain: hypothesis and trial rationale;Frontiers in Pain Research;2024-07-18

4. Diagnosing and managing prescription opioid use disorder in patients prescribed opioids for chronic pain in Australian general practice settings: a qualitative study using the theory of Planned Behaviour;BMC Primary Care;2024-07-03

5. Long-term use of prescription opioids for non-cancer pain and mortality: a population-based, propensity-weighted cohort study;Public Health;2024-07